Diagnsticos (Brazil) Performance
| DASA3 Stock | BRL 2.31 0.07 3.12% |
The firm shows a Beta (market volatility) of 0.53, which means possible diversification benefits within a given portfolio. As returns on the market increase, Diagnsticos' returns are expected to increase less than the market. However, during the bear market, the loss of holding Diagnsticos is expected to be smaller as well. At this point, Diagnsticos da Amrica has a negative expected return of -0.51%. Please make sure to confirm Diagnsticos' market risk adjusted performance, coefficient of variation, jensen alpha, as well as the relationship between the mean deviation and standard deviation , to decide if Diagnsticos da Amrica performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Diagnsticos da Amrica has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 753.6 M | |
| Total Cashflows From Investing Activities | -5 B |
Diagnsticos |
Diagnsticos Relative Risk vs. Return Landscape
If you would invest 330.00 in Diagnsticos da Amrica on August 26, 2024 and sell it today you would lose (99.00) from holding Diagnsticos da Amrica or give up 30.0% of portfolio value over 90 days. Diagnsticos da Amrica is generating negative expected returns and assumes 2.8698% volatility on return distribution over the 90 days horizon. Simply put, 25% of stocks are less volatile than Diagnsticos, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Diagnsticos Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Diagnsticos' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Diagnsticos da Amrica, and traders can use it to determine the average amount a Diagnsticos' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1794
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DASA3 |
Estimated Market Risk
| 2.87 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.51 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Diagnsticos is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Diagnsticos by adding Diagnsticos to a well-diversified portfolio.
Diagnsticos Fundamentals Growth
Diagnsticos Stock prices reflect investors' perceptions of the future prospects and financial health of Diagnsticos, and Diagnsticos fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Diagnsticos Stock performance.
| Return On Equity | -0.0458 | |||
| Return On Asset | 0.0224 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 17.24 B | |||
| Shares Outstanding | 557.11 M | |||
| Price To Earning | 63.21 X | |||
| Price To Book | 1.00 X | |||
| Price To Sales | 0.57 X | |||
| Revenue | 10.42 B | |||
| EBITDA | 1.07 B | |||
| Cash And Equivalents | 832.69 M | |||
| Cash Per Share | 1.76 X | |||
| Total Debt | 6.97 B | |||
| Debt To Equity | 97.70 % | |||
| Book Value Per Share | 13.13 X | |||
| Cash Flow From Operations | 1.3 B | |||
| Earnings Per Share | (0.30) X | |||
| Total Asset | 23.25 B | |||
About Diagnsticos Performance
Assessing Diagnsticos' fundamental ratios provides investors with valuable insights into Diagnsticos' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Diagnsticos is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Diagnsticos da Amrica S.A. provides diagnostic test services in Latin America. Diagnsticos da Amrica S.A. is a subsidiary of Cromossomo Participaes II S.A. DASA ON operates under Diagnostics Research classification in Brazil and is traded on Sao Paolo Stock Exchange.Things to note about Diagnsticos da Amrica performance evaluation
Checking the ongoing alerts about Diagnsticos for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Diagnsticos da Amrica help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Diagnsticos generated a negative expected return over the last 90 days | |
| Diagnsticos has high likelihood to experience some financial distress in the next 2 years | |
| Diagnsticos has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 10.42 B. Net Loss for the year was (226.57 M) with profit before overhead, payroll, taxes, and interest of 3.12 B. | |
| About 56.0% of the company shares are held by company insiders |
- Analyzing Diagnsticos' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Diagnsticos' stock is overvalued or undervalued compared to its peers.
- Examining Diagnsticos' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Diagnsticos' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Diagnsticos' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Diagnsticos' stock. These opinions can provide insight into Diagnsticos' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Diagnsticos Stock Analysis
When running Diagnsticos' price analysis, check to measure Diagnsticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnsticos is operating at the current time. Most of Diagnsticos' value examination focuses on studying past and present price action to predict the probability of Diagnsticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnsticos' price. Additionally, you may evaluate how the addition of Diagnsticos to your portfolios can decrease your overall portfolio volatility.